BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Murata M, Furusyo N, Unno M, Ogawa E, Toyoda K, Taniai H, Ohnishi H, Hayashi J. Long-term effects of lamivudine treatment in Japanese chronic hepatitis B patients. World J Gastroenterol 2011; 17(24): 2945-2952 [PMID: 21734806 DOI: 10.3748/wjg.v17.i24.2945]
URL: https://www.wjgnet.com/1007-9327/full/v17/i24/2945.htm
Number Citing Articles
1
Feng Wu, Min-Jin Wu, Xiao-Lin Zhuge, Shao-Ming Zhu, Biao Zhu. Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatmentHepatobiliary & Pancreatic Diseases International 2012; 11(2): 172 doi: 10.1016/S1499-3872(12)60144-1
2
Robério Amorim de Almeida Pondé, Guilherme de Sousa Pondé Amorim. Exchanges in the ‘a’ determinant of the hepatitis B virus surface antigen revisitedVirology 2024; 599: 110184 doi: 10.1016/j.virol.2024.110184
3
Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, Hachiro Ohnishi, Kazuhiro Toyoda, Hiroaki Taniai, Takeshi Ihara, Hiroaki Ikezaki, Takeo Hayashi, Mosaburo Kainuma, Jun Hayashi. Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analogHepatology Research 2011; 41(12): 1178 doi: 10.1111/j.1872-034X.2011.00869.x
4
LamivudineReactions Weekly 2021; 1850(1): 177 doi: 10.1007/s40278-021-93982-3
5
Mingshun Zhang, Guohong Ge, Yonglin Yang, Xubing Cai, Qiang Fu, Jie Cai, Zuhu Huang. Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutantsVirology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-292
6
Motohiro Shimizu, Norihiro Furusyo, Hiroaki Ikezaki, Eiichi Ogawa, Takeo Hayashi, Takeshi Ihara, Yuji Harada, Kazuhiro Toyoda, Masayuki Murata, Jun Hayashi. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis BWorld Journal of Gastroenterology 2015; 21(7): 2116-2123 doi: 10.3748/wjg.v21.i7.2116